SBC
SBC Medical Group Holdings Incorporated
5.10$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +31.9% | -12.1% | -3.1% | 0.0% | -16.3% | +6.5% | -8.4% | 0.0% | -8.7% | +8.8% | +14.2% | – | |
| – | +37.7% | -19.5% | -10.5% | -28.0% | +7.1% | -9.0% | +39.1% | +0.8% | -20.9% | +22.4% | +1.4% | – | |
| – | +29.5% | -8.9% | -0.3% | +9.7% | -21.7% | +11.4% | -20.5% | -0.4% | -3.3% | +3.8% | +19.8% | – | |
| – | +43.9% | -26.4% | -22.9% | +160.7% | -55.7% | -4.2% | +10.5% | +1.7% | +50.8% | -40.6% | +39.1% | – | |
| – | +43.8% | -22.3% | -19.5% | +142.4% | -0.8% | -53.6% | +14.2% | -9.3% | +14.7% | -23.4% | +38.2% | – | |
| – | +19.8% | +2.0% | +11.6% | -49.3% | -65.9% | +413.0% | -39.9% | +9.1% | -19.1% | +37.9% | +7.0% | – | |
| – | +98.9% | -62.0% | +146.8% | -26.4% | +126.9% | -50.0% | +699.9% | -2.0% | +15.3% | +104.7% | +12.0% | – | |
| – | +11.8% | +15.4% | -0.4% | -51.6% | -53.8% | +419.1% | -56.9% | +36.7% | +0.3% | +1.6% | +3.7% | – | |
| – | -28.3% | -9.5% | +0.9% | +20.5% | -104.8% | – | +11.5% | -48.9% | -24.4% | +75.6% | +3.9% | – | |
| – | +71.6% | +30.8% | -1.5% | -84.7% | +130.8% | +228.8% | -88.6% | +421.7% | +10.7% | -20.4% | -5.4% | – | |
| – | +7.3% | +8.0% | -1.1% | -49.4% | -50.4% | +358.2% | -55.7% | +35.5% | +0.1% | +1.8% | -7.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.